Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 10/20 | 0.61 |
| ▸ | SELE | P16581 | 3/20 | 0.48 |
| ▸ | SELL | P14151 | 1/20 | 0.47 |
| ▸ | SELP | P16109 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17300130 | 0.78 | SELP (0.62) | MAGSELESELLSELP | |
| SCHEMBL29356627 | 0.78 | SELP (0.62) | MAGSELESELLSELP | |
| SCHEMBL29396615 | 0.78 | SELP (0.62) | MAGSELESELLSELP | |
| SCHEMBL29425234 | 0.77 | SELL (0.62) | MAGSELLSELP | |
| SCHEMBL29432515 | 0.77 | SELL (0.68) | MAGSELLSELP | |
| SCHEMBL29533149 | 0.77 | SELL (0.62) | MAGSELLSELP | |
| SCHEMBL11962136 | 0.77 | MAG (0.54) | MAGSELESELLSELP | |
| SCHEMBL8664356 | 0.76 | MAG (0.56) | MAG | |
| SCHEMBL11962144 | 0.75 | MAG (0.53) | MAGSELESELLSELP | |
| SCHEMBL14946228 | 0.75 | MAG (0.52) | MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036386-A1 | Heterobifunctional compounds for selectin inhibition | GLYCOMIMETICS, INC (US) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036386-A1 | Heterobifunctional compounds for selectin inhibition | SELE, SELL, BSG | MAG 370/4885SELE 1/4885SELL 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.